NCT00402597 - Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial) | Biotech Hunter

Enrollment

3,490

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Acute Coronary Syndrome

Interventions

DRUG

Rivaroxaban/Placebo

1 rivaroxaban tablet once daily (and 1 placebo tablet once daily) for 6 months. Safety at each dose level will be confirmed before additional patients are randomized to the next higher dose level.

DRUG

Placebo

1 placebo tablet twice daily for 6 months.

DRUG

Rivaroxaban

1 rivaroxaban tablet twice daily for 6 months. Safety at each dose level will be confirmed before additional patients are randomized to the next higher dose level.